 |
Filip Bergqvist
Senior Scientist, Cytiva Sweden AB
Filip is leading bioanalytical activities to support product development and application work for bioprocessing. His main expertise is LC-MS, where he is developing methods for characterization of proteins and nucleic acid therapeutics.
|
 |
Dr. Jonas Sander
Associate Director Quality Control AS&T, BioNTech Manufacturing GmbH
Jonas holds a Ph.D. in Analytical Chemistry from Saarland University with a focus on hyphenated speciation techniques and trace metal analysis. He joined BioNTech in 2018 as a scientist and later on contributed to the chromatographic methods for Comirnaty release analytics. He is currently working as team lead within the QC department at BioNTech's iNeST Pilot Facility in Mainz.
|
 |
David Muñoz
Principal Biopharma Market Development Manager, Waters Corporation
David will be your host for this event. He completed his PhD in Biochemistry at Nottingham Trent University, focused on the effects of toxins on glioma cells. After this he joined Lonza to work as a research and development scientist using different analytical techniques to characterize antibodies and proteins. Later he worked for Thermo Fisher Scientific as applications specialist and Biopharma Expert, and as business development manager in two CDMOs, focusing on antibodies and viral vector projects. David joined Waters in June 2022 as principal biopharma market development manager.
|
 |
Emma L Harry
European Applications Laboratory Team Manager, Waters Corporation
Emma completed her PhD in Analytical Chemistry at Loughborough University, focused on the development of ion mobility mass spectrometry for complex mixtures.
After her post doctoral research at University of Leicester and having worked as analytical scientist at Hall Analytical, using a variety of analytical techniques, Emma joined Waters in June 2019 as a senior applications chemist in the Demo lab in Wilmslow. In 2021 she was promoted to European applications lab manager.
|
 |
Chris Knowles
Senior Applications Scientist, Waters Corporation
Chris is currently working as a Principal Domain Specialist (Applications science) at Waters, having been with the company for 5 years. He works with the Waters informatics teams to help deliver the waters_connect software applications. His focus has been on the CONFIRM Sequence application. His background is in Bioprocessing, having worked at FUJIFILM Diasynth Biotechnologies for 3 years as a principal scientist in Mammalian cell culture, following completion of a PhD in mammalian cell line engineering at the University of Aberdeen in 2016.
|
 |
Ali Tiss
Sales Specialist Biopharma Chemistry, Europe South, Waters Corporation
Ali completed his Ph.D. in biochemistry and structural biology at the Mediterranean University (CNRS, Marseille, France), where he contributed to the R&D of the anti-obesity drug, Xenical®, developed by Roche Ltd. Then, he spent about 20 years of academic research (France, UK, Kuwait) in biochemistry, liquid chromatography, mass-spectrometry, and proteomics, focusing on detecting and characterizing biomarkers related to human diseases (cancer, diabetes, obesity). Ali joined Waters in October 2021 as a BioPharma and New Modalities Specialist in Chemistry for Southern Europe.
|
